Supply Chain

In June 2005, a physician colleague and I published an article in The Physician Executive magazine entitled: "ABCs of TJR – Physician Involvement Helps build a Profitable Program."

U.S. Senate Judiciary Chairman Chuck Grassley (R-Iowa) said Mylan's seven-page letter addressing the company's nearly 550 percent price hike for EpiPens — which administer life-saving shots of epinephrine to stop allergic reactions — lacked details on how it decided to…

The Food and Drug Administration is proposing to crack down on clinics that offer expensive stem cell therapies for various conditions such as autism, multiple sclerosis and erectile dysfunction, reports STAT.

Insight from the top performers on Gartner's Healthcare Supply Chain 25.

The controversy surrounding the cost of EpiPen's did not stop Fortune from including Mylan CEO Heather Bresch on its "Most Powerful Women" list for 2016.

The Food and Drug Administration will conduct a "thorough investigation" of allegations that St. Jude Medical's heart devices have cybersecurity vulnerabilities, according to Reuters.

Hillary Clinton's plan to monitor and lower the cost of prescription drugs will hinder investments into new drugs and negatively impact consumers Pfizer's CEO Ian Read said Thursday during a webcast at the Wells Fargo's healthcare conference in Boston.

While the pharmaceutical industry has found itself under increasing scrutiny for high drug prices , Fortune recently highlighted the good deeds of four drugmakers in its 2016 "Change the World" list.

Medical device makers are feeling the weight of the Food and Drug Administration's unique device identifier regulations.

While Mylan recently announced it would provide a generic version of its controversially expensive EpiPen, Consumer Reports magazine acknowledged that a cheaper version of the medication already exists.